GALT - Galectin Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Balance Sheet

All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents8,2533,05315,36225,846
Short Term Investments----
Net Receivables----
Other Current Assets6666
Total Current Assets8,8323,81915,79426,400
Long Term Investments----
Property, plant and equipment----
Intangible Assets--18
Accumulated Amortization----
Other Assets174342--
Deferred Long Term Asset Charges----
Total Assets9,0064,16115,79526,408
Current Liabilities
Accounts Payable297608910448
Short/Current Long Term Debt----
Other Current Liabilities299686867
Total Current Liabilities2,1082,9683,7801,360
Long Term Debt----
Other Liabilities----
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities2,1082,9683,7801,360
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock41363328
Retained Earnings-196,215-181,168-163,701-140,049
Treasury Stock----
Capital Surplus194,130173,363166,721157,504
Other Stockholder Equity----
Total stockholders' equity-2,044-7,7693,05317,483
Net Tangible Assets-2,044-7,7693,05217,475